Key result
Diabetes was independently associated with higher odds of CKD in a non-CKDu-endemic region of Sri Lanka.
Why the study?
In Sri Lanka, most epidemiological studies on chronic kidney disease have focused on chronic kidney disease of uncertain etiology in endemic regions, leaving limited data on the prevalence and associated factors of CKD in non-endemic urban populations.
What is the prevalence of chronic kidney disease and its association with cardiometabolic risk factors such as diabetes and hypertension in a non-CKDu endemic adult population in Sri Lanka?
Cross-Sectional (n=1,162)
Yes
What is the prevalence of chronic kidney disease and its association with cardiometabolic risk factors such as diabetes and hypertension in a non-CKDu endemic adult population in Sri Lanka?
In a non-CKDu endemic region of Sri Lanka, CKD affects nearly 1 in 10 adults (standardized prevalence 9.4%) and is primarily driven by diabetes rather than hypertension or dyslipidaemia, supporting routine kidney assessment in diabetes care.
Answers are grounded in this paper and cite their sources.
May inform diabetes-related CKD burden estimates in Sri Lanka; leaves open causal pathways for prospective validation.
Chronic kidney disease (CKD) is an increasing public health challenge in South Asia, driven largely by diabetes and hypertension. In Sri Lanka, most epidemiological studies have focused on chronic kidney disease of uncertain etiology (CKDu) in endemic regions, with limited data from non-endemic urban populations. We estimated the prevalence and associated factors of CKD in the Western Province of Sri Lanka. A population-based cross-sectional survey of adults aged > 20 years used multistage stratified cluster sampling. CKD was defined by a single measurement of estimated glomerular filtration rate < 60 mL/min/1.73 m² and/or urine albumin–creatinine ratio ≥ 30 mg/g. Age- and sex-standardised prevalence was estimated. Two multivariable logistic regression models evaluated clinical cardiometabolic diagnoses and continuous cardiometabolic measurements, respectively. Of 1800 invited individuals, 1408 participated (78.2%); 1162 had complete data. Median age was 50 years (IQR:39–61), and 63.1% were female. Diabetes and hypertension affected 33.9% and 37.5%, respectively. Crude CKD prevalence was 13.1% (95% CI, 11.3–15.2%); standardized prevalence was 9.4% (95% CI, 7.7–11.0%). Stages 1–3a accounted for 86.8% of CKD cases. CKD prevalence was 22.0% among participants with diabetes versus 8.5% without diabetes. In Model 1, diabetes was independently associated with CKD (adjusted OR, 2.13; 95% CI, 1.46–3.11), whereas hypertension and dyslipidaemia were not. In Model 2, higher HbA1c was associated with CKD (adjusted OR per percentage point, 1.23; 95% CI, 1.07–1.41). Both models identified higher odds with increasing age and rural residence, and lower odds in Gampaha versus Colombo. Diabetes was the principal cardiometabolic risk factor independently associated with CKD in this non-CKDu-endemic population in the Western province of Sri Lanka. These findings support integrating kidney assessment into diabetes care, with repeat testing to confirm chronicity. Not applicable.
No takes yet. Share an insight, caveat, or question.
Wijewickrama et al. (2026) conducted a cross-sectional in Chronic kidney disease (CKD) (n=1,162). Diabetes mellitus vs. No diabetes mellitus was evaluated on Prevalence of chronic kidney disease (defined by single measurement of eGFR < 60 mL/min/1.73 m² and/or UACR ≥ 30 mg/g) (OR 2.13, 95% CI 1.46-3.11). Diabetes was independently associated with higher odds of CKD in a non-CKDu-endemic region of Sri Lanka.
Synapse has enriched 10 related papers. Consider them for comparative context: